Infladrop (Bromfenac)

Bromfenac blocks cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in the eye, preventing the formation of prostaglandins that drive inflammation, swelling, and pain, thereby providing rapid anti‑inflammatory relief.

The dosing regimen for Infladrop is determined by the prescribing ophthalmologist. Typically, a few drops are instilled in the affected eye(s) at intervals recommended by the clinician, based on the surgical procedure and patient response.

Safety data for bromfenac eye drops in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any possible risk, and the decision rests with the treating physician.

To order Infladrop, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Infladrop delivers bromfenac, a potent COX‑inhibitor with a high affinity for ocular tissues, offering rapid pain relief and inflammation control. Compared with older agents like diclofenac, bromfenac often provides longer duration of action and may require fewer daily administrations.

Infladrop should be stored at room temperature, away from direct sunlight. Keep the bottle tightly closed, in its original packaging, and protect it from moisture to maintain sterility and potency.

The patient instills the prescribed number of drops into the affected eye(s) using the provided dropper, typically without touching the tip to the eye or surrounding tissues. Hands should be washed before use, and the bottle should be capped immediately after each dose.

Serious risks include corneal ulceration, significant increases in intra‑ocular pressure, severe allergic reactions, and rare cases of vision loss. Any sudden worsening of vision, persistent pain, or signs of infection should prompt immediate medical evaluation.

Patients with known hypersensitivity to bromfenac or any component of the formulation, those with active ocular infections, and individuals with uncontrolled glaucoma should avoid using Infladrop unless directed otherwise by an eye care professional.